Rural areas had faster increases in distant-stage incidence rates, slower decreases in mortality for cancers amenable to early detection ...

In this retrospective cohort study, researchers evaluated implementation of a carboplatin allocation plan during a carboplatin shortage.

In this analysis, researchers aimed to estimate patterns of prostate cancer among transgender women receiving gender-affirming hormone therapy, relative to those of cisgender men.

New ACOG guidance says benefits outweigh risks for most women, with nonhormonal options for those who can’t take hormones ...

(HealthDay News) — Adverse family outcomes are reported in children with B-cell acute lymphoblastic leukemia (B-ALL), according to a study published in the Journal of the National Comprehensive Cancer ...

In this study, researchers calculated a national estimate of lung cancer screening-eligible individuals, including estimates based on demographic variables and geographic regions.

In this phase3 trial, researchers explored whether a chemotherapy-free strategy was superior to a tyrosine kinase inhibitor plus chemotherapy in Ph-positive ALL.

The application for the next-generation mitomycin formulation is supported by 3-month complete response data from the phase 3 UTOPIA trial.

In this analysis, researchers examined the association of quality of life and functional outcomes with organ preservation following total neoadjuvant treatment among patients with rectal cancer.

Dr Don Dizon discusses how social media can break down barriers between clinicians and patients and why oncologists should ...

In the LIGHT trial, researchers compared carbon dioxide laser therapy and sham laser therapy for breast cancer survivors receiving AIs who presented with GSM and dyspareunia.

Inverse correlation reported for pathogenic variant prevalence with age at diagnosis, but prevalence was 12.3 percent in late-onset tumors ...